Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

13.3%

4 terminated out of 30 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

10%

3 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results67% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (5)
P 1 (4)
P 2 (6)
P 3 (1)
P 4 (2)

Trial Status

Unknown9
Completed8
Recruiting7
Terminated4
Withdrawn2

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (30)

Showing 20 of 20 trials
NCT07265544RecruitingPrimary

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

NCT07413640RecruitingPrimary

Variability of Microwave Ablation Volume Based on Clinical, Radiological, Biological, and Tissue Factors

NCT07335042Recruiting

Prediction Model for MINS After Major Hepatobiliary Surgery

NCT04864054Phase 1Recruiting

T-Cell Therapy (ECT204) in Adults With Advanced HCC

NCT07145801Phase 2Recruiting

Y-90 Treatment Response Using Transarterial Radioembolization

NCT04502082Phase 1Terminated

Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)

NCT06555003Phase 3RecruitingPrimary

DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases

NCT05848947Phase 4Completed

SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA

NCT06775158CompletedPrimary

Perioperative Myocardial and Renal Injury in Patients Undergoing Hepatic Resection

NCT05169177RecruitingPrimary

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy

NCT00906984Unknown

TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma

NCT02571946Not ApplicableCompletedPrimary

Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

NCT04010071Phase 2Unknown

Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors

NCT05723705Unknown

Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT)

NCT03803436Phase 2Unknown

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

NCT03998033Phase 1Terminated

Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma

NCT05495529Completed

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors

NCT04187937Not ApplicableTerminatedPrimary

Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections

NCT04702230TerminatedPrimary

Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization

NCT02471313Phase 2Completed

Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization

Scroll to load more

Research Network

Activity Timeline